References
- Sands M, Kron M A, Brown RB. Pentamidine: a review. Rev Infect Dis 1985; 7: 625–634
- Webster L T, Jr. Drugs used in the chemotherapy of protozoal infections. Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th Ed., AG Gilman, TW Rall, AS Nies, P Taylor. Pergamon Press, New York 1990; 1011–1013
- Wispelwey B, Pearson R. Pentamidine. A risk-benefit analysis. Drug Saf 1990; 5: 212–219
- Drug Package Insert, Pentam, Fujisawa USA, Inc. Deerfield, IL 1995
- Conte JE, Jr., Upton R A, Phelps R T, Wofsky C B, Zurlinden E, Lin ET. Use of a specific and sensitive assay to determine pentamidine pharmacokinetic in patients with AIDS. J Infect Dis 1986; 154: 923–929
- Katona B G, Siegel E C, Cluxton RJ, Jr. The new black magic: activated charcoal and new therapeutic uses. J Emerg Med 1987; 5: 9–18
- Western K A, Perera D R, Schultz MG. Pentamidine isethionate in the treatment of Pneumocystis carinii pneumonia. Ann Intern Med 1970; 73: 695–702
- Stark F R, Crast F, Clemmer T, Ramirez R. Fatal herxheimer reaction after pentamidine in pneumocystis pneumonia. Lancet 1976; 1: 1193–1194
- Miller HC. Cardiac arrest after intravenous pentamidine in an infant. Pediatr Infect Dis J 1933; 12: 694–696
- Conte J E, Jr. Pharmacokinetics of intravenous pentamidine in patients with normal renal function or receiving hemodialysis. J Infect Dis 1991; 163: 169–175